/ /

  • linkedin
  • Increase Font
  • Sharebar

    Top 5 neuro signs never to ignore

    Let’s examine case-based examples to emphasize the top five neuro-ophthalmic disorders that should not be overlooked.

    These include:

    • Acute painful loss of vision in elderly due to giant cell arteritis

    • Acute painful ophthalmoplegia due to orbital apex disease

    • Acute painful bitemporal hemianopsia due to pituitary apoplexy

    • Acute painful anisocoria with a small pupil due to a Horner syndrome

    • Acute painful anisocoria with a large pupil due to a pupil involved third nerve palsy from aneurysm

    Clinicians should be aware of the key and distinctive clinical and radiographic findings for each of these potentially vision- or life-threatening conditions.

    1. Acute painful vision loss in the elderly

    A 75-year-old male presents with acute vision loss in the right eye to the 20/200 level associated with new headaches. This presentation is classic for giant cell arteritis (GCA). The diagnosis of GCA should be considered in any elderly patient with any acute neuro-ophthalmic complaint with or without pain.

    The most common presenting symptoms of GCA, however, are intermittent or constant visual loss, new onset headaches, jaw claudication, and scalp tenderness.1-4

    Hayreh et al reported 106 of 363 patients with biopsy-proven GCA. The odds of a positive biopsy were 9.0 times greater with jaw claudication (P < 0.0001), 3.4 times greater with neck pain (P=0.0085), 2.0 times greater with an erythrocyte sedimentation rate (ESR) of 47 to 107 mm/hour (P=0.0454), 3.2 times greater with C-reactive protein above 2.45 mg/dl (P=0.0208), and 2.0 times greater for age 75 years or more (P=0.0105).5

    The treatment of choice for GCA is immediate high-dose systemic steroids; however the route is still controversial.3,6-8


    You must be signed in to leave a comment. Registering is fast and free!

    All comments must follow the ModernMedicine Network community rules and terms of use, and will be moderated. ModernMedicine reserves the right to use the comments we receive, in whole or in part,in any medium. See also the Terms of Use, Privacy Policy and Community FAQ.

    • No comments available

    Optometry Times A/V